ICON strengthens global scientific council
This article was originally published in Scrip
CRO ICON has appointed Professor Brendan Buckley and Dr Nicholas Alp to the company's global scientific council. Professor Buckley has been appointed senior vice-president of medical affairs, having joined ICON in July 2011 through the company's acquisition of Firecrest Clinical. Dr Alp has been appointed vice-president and therapeutic area leader for cardiovascular. Prior to joining ICON, Dr Alp held senior appointments in cardiovascular medicine at Oxford University, and as a consultant interventional cardiologist at Oxford Radcliffe Hospitals NHS Trust.
You may also be interested in...
Perhaps only a man who inherited an enthusiasm for peptides could, without a trace of irony, cast diabetes drug development as the work of a pastry chef. But for David Solomon, the son of a peptide devotee, mixed metaphors and stretched comparisons are simply the spray thrown up by his unbridled enthusiasm for his chosen trade, that of basketball coach to GLP-1 receptor agonist developer Zealand Pharma.
"How the hell will Glaxo need you? You've only got a few people, they've got about 50,000!"